Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
Clinical trial NCT05097989 · TERMINATED
Trial details
- NCT number
- NCT05097989
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2024-12-09
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.